Surgical site infections after arthroscopy: Outbreak investigation and case control study

Babcock, Hilary M.; Carroll, C.; Matava, Matthew J.; L'Ecuyer, Paul B.; Fraser, Victoria J.

doi:10.1053/jars.2003.50016

Cited by 56 publications

(42 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…738,749,756 Antimicrobial prophylaxis in patients undergoing diagnostic and operative arthroscopic procedures is controversial. 6,[757][758][759][760] The risks of SSI and long-term sequelae are low for procedures not involving implantation.…”

Section: Clean Orthopedic Procedures Not Involving Implantation Of Fomentioning

confidence: 99%

Clinical practice guidelines for antimicrobial prophylaxis in surgery

Bratzler

Dellinger

Olsen

et al. 2013

American Journal of Health-System Pharmacy

1,883

1,464

View full text Add to dashboard Cite

Section: Clean Orthopedic Procedures Not Involving Implantation Of Fomentioning

confidence: 99%

Clinical practice guidelines for antimicrobial prophylaxis in surgery

Bratzler

Dellinger

Olsen

et al. 2013

American Journal of Health-System Pharmacy

1,883

1,464

View full text Add to dashboard Cite

“…The prevalence of non-albicans species of Candida and the proportion of fluconazole-resistant Candida albicans isolates is increasing due to widespread use of antifungal azole prophylaxis. [89] Internationally, widespread use of fluoroquinolone prophylaxis for neutropenic patients has been associated with the emergence of resistant gram-negative isolates. [90,91] The emergence of resistant bacterial isolates -including vancomycin-resistant enterococci (VRE), [92] MRSA [93] and multiresistant gram-negative organisms [92] -is likely to have happened at the same time as the circulation of endemic and outbreak strains within non-haematology populations in individual health-care institutions.…”

Section: Haematology-oncology Patientsmentioning

confidence: 99%

“…Identification of VRE-colonised patients and implementation of contact isolation have been shown to be cost-effective and may reduce morbidity and mortality in populations at high risk for VRE acquisition. [88,89] Routine surveillance markedly increases the detection of VRE compared to reliance on clinical specimens. [90] Using mathematical models, passive surveillance without screening has been predicted to prevent few cases in high-risk settings.…”

Section: Introductionmentioning

confidence: 99%

Characterising health care‐associated bloodstream infections in public hospitals in Queensland, 2008–2012

Runnegar

Marquess

et al. 2016

Medical Journal of Australia

View full text Add to dashboard Cite

Objective: To describe the epidemiology and rates of all health care‐associated bloodstream infections (HA‐BSIs) and of specific HA‐BSI subsets in public hospitals in Queensland. Design and setting: Standardised HA‐BSI surveillance data were collected in 23 Queensland public hospitals, 2008–2012. Main outcome measures: HA‐BSIs were prospectively classified in terms of place of acquisition (inpatient, non‐inpatient); focus of infection (intravascular catheter‐associated, organ site focus, neutropenic sepsis, or unknown focus); and causative organisms. Inpatient HA‐BSI rates (per 10 000 patient‐days) were calculated. Results: There were 8092 HA‐BSIs and 9418 causative organisms reported. Inpatient HA‐BSIs accounted for 79% of all cases. The focus of infection in 2792 cases (35%) was an organ site, intravascular catheters in 2755 (34%; including 2240 central line catheters), neutropenic sepsis in 1063 (13%), and unknown in 1482 (18%). Five per cent (117 of 2240) of central line‐associated BSIs (CLABSIs) were attributable to intensive care units (ICUs). Eight groups of organisms provided 79% of causative agents: coagulase‐negative staphylococci (18%), Staphylococcus aureus (15%), Escherichia coli (11%), Pseudomonas species (9%), Klebsiella pneumoniae/oxytoca (8%), Enterococcus species (7%), Enterobacter species (6%), and Candida species (5%). The overall inpatient HA‐BSI rate was 6.0 per 10 000 patient‐days. The rates for important BSI subsets included: intravascular catheter‐associated BSIs, 1.9 per 10 000 patient‐days; S. aureus BSIs, 1.0 per 10 000 patient‐days; and methicillin‐resistant S. aureus BSIs, 0.3 per 10 000 patient‐days. Conclusions: The rate of HA‐BSIs in Queensland public hospitals is lower than reported by similar studies elsewhere. About one‐third of HA‐BSIs are attributable to intravascular catheters, predominantly central venous lines, but the vast majority of CLABSIs are contracted outside ICUs. Different sources of HA‐BSIs require different prevention strategies.

show abstract

“…The health care costs include the costs of the epidemiological investigation of the outbreak, the diagnosis and treatment of the affected patients, and the use of resources cost associated with endoscope unit inactivity. A study of post-arthroscopy infections estimated the cost approximately at $9,155 per case (Babcock et al, 2003). The economic evaluation of the microbiological surveillance should include a calculation of the costs for the microbiological tests, costs in time for nursing staff to collect the samples, costs of endoscope recall and extra disinfection procedures or service of the endoscopes.…”

Section: Economic Burden Of Endoscope Reprocessing and Endoscopy-relamentioning

confidence: 99%